Us Bancorp \De\ Ani Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 63 shares of ANIP stock, worth $3,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 63 -0.0%

Holding current value

$3,564

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$58.53 - $68.82 $5,209 - $6,124	-89 Reduced 58.55%	63 $4,000
Q3 2022 Oct 27, 2022	SELL	$29.83 - $38.01 $656 - $836	-22 Reduced 12.64%	152 $5,000
Q2 2022 Aug 01, 2022	SELL	$23.09 - $33.46 $8,958 - $12,982	-388 Reduced 69.04%	174 $5,000
Q1 2022 May 11, 2022	SELL	$26.91 - $47.15 $457 - $801	-17 Reduced 2.94%	562 $16,000
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $3,428 - $5,912	104 Added 21.89%	579 $27,000
Q3 2021 Nov 10, 2021	BUY	$26.48 - $35.99 $11,916 - $16,195	450 Added 1800.0%	475 $16,000
Q1 2021 Apr 28, 2021	BUY	$28.4 - $36.14 $710 - $903	25 New	25 $1,000
Q4 2020 Feb 04, 2021	SELL	$23.69 - $31.47 $592 - $786	-25 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$26.38 - $33.1 $10,103 - $12,677	-383 Reduced 93.87%	25 $1,000
Q2 2020 Aug 07, 2020	SELL	$29.93 - $50.1 $3,980 - $6,663	-133 Reduced 24.58%	408 $13,000
Q1 2020 May 13, 2020	BUY	$30.35 - $67.14 $16,419 - $36,322	541 New	541 $22,000
Q2 2018 Aug 08, 2018	SELL	$56.38 - $68.08 $2,311 - $2,791	-41 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$56.98 - $72.41 $1,937 - $2,461	-34 Reduced 45.33%	41 $2,000
Q4 2017 Feb 02, 2018	SELL	$53.3 - $74.56 $18,761 - $26,245	-352 Reduced 82.44%	75 $5,000
Q3 2017 Nov 13, 2017	BUY	$43.46 - $52.49 $18,557 - $22,413	427	427 $22,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account